Ikarian Capital, LLC
Q4 2025 13F Holdings
- Locationdallas, TX
- Num holdings
174
- Value ($000)
$1,280,884
- Date Filed02/17/2026
- Form type13F-HR
- CIK0001778253
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
SPDR SERIES TRUST | STATE STREET SPD | 78464A870 | $103.64M | 8 % | 850,000 | put | |
CIDARA THERAPEUTICS INC | COM NEW | 171757206 | $66.27M | 5 % | 300,000 | put | |
AMGEN INC | COM | 031162100 | $65.46M | 5 % | 200,000 | put | |
TERNS PHARMACEUTICALS INC | COM | 880881107 | $64.49M | 5 % | 1,596,378 | ||
CIDARA THERAPEUTICS INC | COM NEW | 171757206 | $60.36M | 5 % | 273,243 | ||
ABIVAX SA | SPONSORED ADS | 00370M103 | $29.13M | 2 % | 205,985 | ||
JAZZ PHARMACEUTICALS PLC | CALL | G50871905 | $28.9M | 2 % | 170,000 | call | |
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $27.26M | 2 % | 160,367 | ||
MAZE THERAPEUTICS INC | COM | 578784100 | $26.71M | 2 % | 644,680 | ||
PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | $25.52M | 2 % | 86,581 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100